In response to a solicitation from the National Center for Advancing Translational Science (NCATS) to help set priorities and inform the development of its first five-year strategic plan, the Federation of American Societies for Experimental Biology (FASEB) sent a letter to NCATS Director Christopher Austin, MD, detailing suggestions for the Center’s future directions. Established in 2011, NCATS is devoted to accelerating translation of basic biomedical research discoveries to clinical applications.
The December 2 letter reiterated themes from FASEB’s report Engaging Basic Scientists in Translational Research: Identifying Opportunities, Overcoming Obstacles and drew upon previous comments submitted to NCATS. Specifically, FASEB recommended that the center:
Comments on the NCATS strategic plan are being accepted until January 8.
- Continue to enhance the Clinical and Translational Science Awards (CTSA) Program
- Offer training in translational methods for both basic and clinical scientists
- Foster cross-discipline collaborations and providing access to resources
- Increase interactions with the patient community
- Develop mechanisms for recognizing and rewarding scientific contributions in translational research